PTK2 and esophageal squamous cell carcinoma: α5β1 integrin expression is significantly upregulated in cisplatin-resistant esophageal SCC cell lines Eca109 and TE-1 and contributes to cisplatin resistance by activating the FAK/PI3K/Akt/BRAD1 signaling pathway [47].